🔎 Trials Near Me

Akèy › Kansè vejik › Iowa › Des Moines

Etid klinik pou Kansè vejik nan Des Moines, IA

6 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Des Moines (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Ap rekriteEtid obsèvasyonVolontè an sante akeyi
  • Iowa Methodist Medical Center, Des Moines
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
  • Mercy Medical Center - Des Moines, Des Moines
  • ak 6 plis
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

Ap rekriteFaz 2
  • Iowa Methodist Medical Center, Des Moines
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
  • Broadlawns Medical Center, Des Moines
  • ak 7 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06770582

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Ap rekriteFaz 2
  • Iowa Methodist Medical Center, Des Moines
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
  • Mercy Medical Center - Des Moines, Des Moines
  • ak 6 plis
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07061964

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Ap rekriteFaz 2
  • Iowa Methodist Medical Center, Des Moines
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
  • Mercy Medical Center - Des Moines, Des Moines
  • ak 4 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT03866382

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

Ap rekriteFaz 2
  • Urology Center of Iowa Research, Clive · 6 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06567743

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

Ap rekriteFaz 3
  • Iowa Methodist Medical Center, Des Moines
  • UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines
  • Mercy Medical Center - Des Moines, Des Moines
  • ak 7 plis
Laj 18 ak plis · Tout sèks · Mizajou Aug 18, 2026 · NCT07097142

Etid Kansè vejik nan lòt vil

Lòt etid nan Des Moines

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.